INSIGHT

Q1-2019 Dermatology Update

The dermatology sector continues to see robust transaction volume, attributable to the multitude of strategic platforms consolidating their respective markets. However, while transaction volume has remained elevated, private equity recapitalizations have been far and few between in recent quarters. The first quarter of 2019 marked the third consecutive quarter without a platform transaction. In a sector with an abundance of private equity backed-platforms, and a scarcity of sizable, independent practices, Provident expects this trend to continue until new funds start to seek out established, private equity-backed platforms to invest in. With the market maturing and many groups having had institutional backing for 3+ years, Provident expects secondary transactions to start to occur throughout the balance of the year.

To print and download the full Dermatology Update report, please click below…

 

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.
  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”